Author:
Ng Zhi Xiang,Yong Phaik Har
Publisher
Springer International Publishing
Reference108 articles.
1. Abidov M, Ramazanov A, Jimenez Del Rio M, Chkhikvishvili I (2006) Effect of blueberin on fasting glucose, C-reactive protein and plasma aminotransferases, in female volunteers with diabetes type 2: double-blind, placebo controlled clinical study. Georgian Med News 141:66–72
2. Agraharam G, Girigoswami A, Girigoswami K (2022) Myricetin: a multifunctional flavonol in biomedicine. Curr Pharmacol Rep 8(1):48–61. https://doi.org/10.1007/s40495-021-00269-2
3. Ahrens MJ, Thompson DL (2013) Effect of emulin on blood glucose in type 2 diabetics. J Med Food 16(3):211–215. https://doi.org/10.1089/jmf.2012.0069
4. Ahrens MJ, Thompson DL (2021) Composition for treating diabetes and metabolic disorders with quercetin, myricetin and chlorogeneic acid. EP Patent 2129371 B1, 5 May 2021
5. Akhtar S, Najafzadeh M, Isreb M, Newton L, Gopalan RC, Anderson D (2020) An in vitro investigation into the protective and genotoxic effects of myricetin bulk and nano forms in lymphocytes of MGUS patients and healthy individuals. Toxicol Lett 327:33–40. https://doi.org/10.1016/j.toxlet.2020.03.012